Transcranial magnetic stimulation as a tool to understand genetic conditions associated with epilepsy

Katri SilvennoinenSimona BalestriniJohn C. RothwellSanjay M. Sisodiya

First published: 12 August 2020

Funding Information:

This study was supported by EC grant 279062, EpiPGX. This work was partly carried out at NIHR University College London Hospitals Biomedical Research Centre, which receives a proportion of funding from the UK Department of Health’s NIHR Biomedical Research Centres funding scheme. Additional funding was provided by the Epilepsy Society. KS is supported by a Wellcome Trust Strategic Award (WT104033AIA). TMS work is additionally supported by grant funding from UCB to Epilepsy Society.


0 0 vote
Article Rating
Notify of
Inline Feedbacks
View all comments

Related Post

‘AHC and ATP1A3 Natural History Study’ Q&A session with Dr. Katerina Vezyroglou‘AHC and ATP1A3 Natural History Study’ Q&A session with Dr. Katerina Vezyroglou

Thank you to everyone who joined in this helpful Question & Answer session in November of last year with Dr. Katerina Vezyroglou on her research work. As promised, we have included the link to the recorded zoom session for those of you who were unable to attend the event.    We hope you find this helpful and as in the session,  Dr. Vezyrouglou is very happy to hear from anyone who would like to ask  any more questions. All questions are welcome.    As discussed in the zoom chat, this project also feeds into the OBSERV AHC natural history study involving many international centers.  

Would love your thoughts, please comment.x